(2014) Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study
But several profiles make thorough baseline testing genuinely non-negotiable: Any history of type 2 diabetes or prediabetes (HbA1c monitoring changes medication management) Personal or family history of medullary thyroid carcinoma or MEN2 syndrome (direct contraindication) History of pancreatitis (GLP-1 medications carry a pancreatitis warning) Chronic kidney disease or known renal impairment Current use of insulin, metformin, or other glucose-lowering medications (drug interaction and hypoglycemia risk) History of eating disorders, severe gastroparesis, or significant GI conditions PCOS or other hormonal conditions that drive weight-related metabolic dysfunction 1.3 What clinical guidelines say The American Diabetes Association (ADA) Standards of Medical Care recommend HbA1c, renal function, and lipid panels as part of baseline metabolic assessment before initiating GLP-1 therapy in patients with diabetes
It carries the same cardiovascular risk-reduction indication as the injectable form
A properly balanced diet contains a substantial amount of LC as well as essential amino acids and microelements taking part in endogenous carnitine synthesis
C CH HOT NG CA GLUTATHIONE Glutathione tham gia vo nhiu qu trnh trong c th, bao gm xy dng, sa cha m, to ra cc ha cht v protein cn thit trong c th v cho h thng min dch
